documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
80 rows where docket_id = "FDA-2011-N-0003" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
document_type 4
- Rule 45
- Supporting & Related Material 31
- Notice 2
- Other 2
agency_id 1
- FDA 80
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2011-N-0003-0081 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 141-324 Phenylpropanolamine | Supporting & Related Material | Freedom of Information Summary | 2012-03-19T04:00:00Z | 2012 | 3 | 2012-03-19T19:03:24Z | 0 | 0 | 0900006480fdb2bc | |||
| FDA-2011-N-0003-0080 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 141-331 Pergolide | Supporting & Related Material | Freedom of Information Summary | 2012-03-19T04:00:00Z | 2012 | 3 | 2012-03-19T16:43:41Z | 0 | 0 | 0900006480fda89d | |||
| FDA-2011-N-0003-0079 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Phenylpropanolamine | Rule | Final Rule | 2012-03-19T04:00:00Z | 2012 | 3 | 2012-03-19T04:00:00Z | 2012-03-19T16:36:30Z | 2012-06553 | 0 | 0 | 0900006480fdac8f | |
| FDA-2011-N-0003-0078 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Pergolide | Rule | Final Rule | 2012-03-19T04:00:00Z | 2012 | 3 | 2012-03-19T04:00:00Z | 2012-03-19T13:39:39Z | 2012-06544 | 0 | 0 | 0900006480fdac97 | |
| FDA-2011-N-0003-0077 | FDA | None FDA-2011-N-0003 | Animal Drugs, Feeds, and Related Products: N-Methyl-2-Pyrrolidone; Correction | Rule | Correction | 2012-02-17T05:00:00Z | 2012 | 2 | 2012-02-17T05:00:00Z | 2012-02-17T14:12:13Z | 2012-03747 | 0 | 0 | 0900006480fb8faf | |
| FDA-2011-N-0003-0076 | FDA | None FDA-2011-N-0003 | FDA/DDM Courtesy Letter to the Holders of Applications - Letter | Other | Letter(s) | 2012-02-16T05:00:00Z | 2012 | 2 | 2012-02-16T05:00:00Z | 2012-02-16T23:45:05Z | 0 | 0 | 0900006480fac666 | ||
| FDA-2011-N-0003-0075 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor; Chlortetracycline Powder | Rule | 2012-02-06T05:00:00Z | 2012 | 2 | 2012-02-06T05:00:00Z | 2012-02-06T17:48:19Z | 2012-02633 | 0 | 0 | 0900006480fae382 | ||
| FDA-2011-N-0003-0073 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Chloramphenicol, Diethylcarbamazine Citrate, Hygromycin B, Methoxyflurane, Neomycin Sulfate, Penicillin G, Phenylbutazone,etc. | Rule | Final Rule | 2012-02-01T05:00:00Z | 2012 | 2 | 2012-02-01T05:00:00Z | 2012-02-01T15:16:51Z | 2012-02103 | 0 | 0 | 0900006480faacf8 | |
| FDA-2011-N-0003-0074 | FDA | None FDA-2011-N-0003 | Withdrawal of Approval of New Animal Drug Applications | Notice | General Notice | 2012-02-01T05:00:00Z | 2012 | 2 | 2012-02-01T05:00:00Z | 2012-02-01T15:47:20Z | 2012-02109 | 0 | 0 | 0900006480faacba | |
| FDA-2011-N-0003-0063 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary ANDA 200-494 - Gentamicin Sulfate | Supporting & Related Material | Freedom of Information Summary | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T14:18:17Z | 0 | 0 | 0900006480fa722e | |||
| FDA-2011-N-0003-0067 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 141-207 - Danofloxacin | Supporting & Related Material | Freedom of Information Summary | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T14:33:04Z | 0 | 0 | 0900006480fa7232 | |||
| FDA-2011-N-0003-0062 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Gentamicin Sulfate | Rule | Final Rule | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T14:11:48Z | 2012-01753 | 0 | 0 | 0900006480fa6f59 | ||
| FDA-2011-N-0003-0065 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 141-322 - Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate | Supporting & Related Material | Freedom of Information Summary | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T14:24:50Z | 0 | 0 | 0900006480fa7230 | |||
| FDA-2011-N-0003-0069 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 095-735 - Monensin | Supporting & Related Material | Freedom of Information Summary | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T15:00:40Z | 0 | 0 | 0900006480fa729f | |||
| FDA-2011-N-0003-0071 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Milbemycin Oxime, Lufenuron, and Praziquantel | Rule | Final Rule | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T15:09:20Z | 2012-01744 | 0 | 0 | 0900006480fa7022 | ||
| FDA-2011-N-0003-0064 | FDA | None FDA-2011-N-0003 | Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate | Rule | Final Rule | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T14:20:52Z | 2012-01754 | 0 | 0 | 0900006480fa6f61 | ||
| FDA-2011-N-0003-0072 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 141-333 - Milbemycin Oxime, Lufenuron, and Praziquantel | Supporting & Related Material | Reference (internal unless indicated) | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T15:12:54Z | 0 | 0 | 0900006480fa72a3 | |||
| FDA-2011-N-0003-0068 | FDA | None FDA-2011-N-0003 | New Animal Drugs for Use in Animal Feeds: Monensin | Rule | Final Rule | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T14:56:44Z | 2012-01755 | 0 | 0 | 0900006480fa6ff0 | ||
| FDA-2011-N-0003-0070 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor's Name | Rule | Final Rule | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T15:05:48Z | 2012-01756 | 0 | 0 | 0900006480fa6ff4 | ||
| FDA-2011-N-0003-0066 | FDA | None FDA-2011-N-0003 | Implantation or Injectable Dosage Form New Animal Drugs: Danofloxacin | Rule | Final Rule | 2012-01-27T05:00:00Z | 2012 | 1 | 2012-01-27T14:27:44Z | 2012-01743 | 0 | 0 | 0900006480fa6f98 | ||
| FDA-2011-N-0003-0061 | FDA | None FDA-2011-N-0003 | reedom of Information Summary NADA 141-203 Deracoxib | Supporting & Related Material | Freedom of Information Summary | 2012-01-26T05:00:00Z | 2012 | 1 | 2012-01-26T14:22:22Z | 0 | 0 | 0900006480fa50c0 | |||
| FDA-2011-N-0003-0060 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Deracoxib | Rule | Final Rule | 2012-01-26T05:00:00Z | 2012 | 1 | 2012-01-26T14:09:02Z | 2012-01622 | 0 | 0 | 0900006480fa5564 | ||
| FDA-2011-N-0003-0058 | FDA | None FDA-2011-N-0003 | Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Spray | Rule | Final Rule | 2012-01-25T05:00:00Z | 2012 | 1 | 2012-01-25T05:00:00Z | 2012-01-25T21:11:07Z | 2012-01501 | 0 | 0 | 0900006480fa3c14 | |
| FDA-2011-N-0003-0059 | FDA | None FDA-2011-N-0003 | Gentamicin Topical Spray (gentamicin sulfate, betamethasone valerate- ANADA 200-416; Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2012-01-25T05:00:00Z | 2012 | 1 | 2012-01-25T21:52:45Z | 0 | 0 | 0900006480fa4961 | |||
| FDA-2011-N-0003-0057 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary ANDA 200-318 Bimectin Pour-On (Ivermectin) | Supporting & Related Material | Reference (internal unless indicated) | 2011-12-29T05:00:00Z | 2011 | 12 | 2011-12-29T14:03:11Z | 0 | 0 | 0900006480f8ad17 | |||
| FDA-2011-N-0003-0056 | FDA | None FDA-2011-N-0003 | Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution | Rule | Final Rule | 2011-12-29T05:00:00Z | 2011 | 12 | 2011-12-29T05:00:00Z | 2011-12-29T13:58:17Z | 2011-33382 | 0 | 0 | 0900006480f8acdf | |
| FDA-2011-N-0003-0054 | FDA | None FDA-2011-N-0003 | New Animal Drugs for Use in Animal Feeds: Monensin | Rule | Final Rule | 2011-12-21T05:00:00Z | 2011 | 12 | 2011-12-21T05:00:00Z | 2011-12-21T22:06:14Z | 2011-32427 | 0 | 0 | 0900006480f87099 | |
| FDA-2011-N-0003-0055 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor; Zinc Gluconate | Rule | Final Rule | 2011-12-21T05:00:00Z | 2011 | 12 | 2011-12-21T05:00:00Z | 2011-12-21T22:32:43Z | 2011-32591 | 0 | 0 | 0900006480f87170 | |
| FDA-2011-N-0003-0052 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Cyclosporine | Rule | Final Rule | 2011-12-20T05:00:00Z | 2011 | 12 | 2011-12-20T05:00:00Z | 2011-12-20T15:34:59Z | 2011-32526 | 0 | 0 | 0900006480f864a7 | |
| FDA-2011-N-0003-0053 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 141-329 Cyclosporine | Supporting & Related Material | Freedom of Information Summary | 2011-12-20T05:00:00Z | 2011 | 12 | 2011-12-20T17:17:34Z | 0 | 0 | 0900006480f86905 | |||
| FDA-2011-N-0003-0049 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 141-325 Incurin (Estriol) | Supporting & Related Material | Freedom of Information Summary | 2011-12-16T05:00:00Z | 2011 | 12 | 2011-12-16T18:43:16Z | 0 | 0 | 0900006480f843e3 | |||
| FDA-2011-N-0003-0048 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Estriol | Rule | Final Rule | 2011-12-16T05:00:00Z | 2011 | 12 | 2011-12-16T05:00:00Z | 2011-12-16T18:28:06Z | 2011-32214 | 0 | 0 | 0900006480f84681 | |
| FDA-2011-N-0003-0050 | FDA | None FDA-2011-N-0003 | Ophthalmic and Topical Dosage Form New Animal Drugs: Hydrocortisone Aceponate, Miconazole Nitrate, and Gentamicin Sulfate Otic Suspension | Rule | Final Rule | 2011-12-16T05:00:00Z | 2011 | 12 | 2011-12-16T05:00:00Z | 2011-12-16T19:26:27Z | 2011-32226 | 0 | 0 | 0900006480f846b9 | |
| FDA-2011-N-0003-0051 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 141-330 EASOTIC | Supporting & Related Material | Freedom of Information Summary | 2011-12-16T05:00:00Z | 2011 | 12 | 2011-12-20T17:21:00Z | 0 | 0 | 0900006480f844a8 | |||
| FDA-2011-N-0003-0045 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary NADA 141-064 Pulmotil 90 Tilmicosin | Supporting & Related Material | Reference (internal unless indicated) | 2011-12-09T05:00:00Z | 2011 | 12 | 2011-12-09T18:12:30Z | 0 | 0 | 0900006480f7f1b7 | |||
| FDA-2011-N-0003-0046 | FDA | None FDA-2011-N-0003 | Enviromental Risk Assessment NADA 141-064 | Supporting & Related Material | Reference (internal unless indicated) | 2011-12-09T05:00:00Z | 2011 | 12 | 2011-12-09T18:16:50Z | 0 | 0 | 0900006480f7f1b9 | |||
| FDA-2011-N-0003-0044 | FDA | None FDA-2011-N-0003 | New Animal Drugs for Use in AnimalFeeds: Tilmicosin | Rule | Final Rule | 2011-12-09T05:00:00Z | 2011 | 12 | 2011-12-09T16:06:45Z | 2011-31613 | 0 | 0 | 0900006480f7edc7 | ||
| FDA-2011-N-0003-0047 | FDA | None FDA-2011-N-0003 | Finding of No Significant Impact (FONSI) - NADA 141-064 | Supporting & Related Material | Reference (internal unless indicated) | 2011-12-09T05:00:00Z | 2011 | 12 | 2011-12-09T18:21:05Z | 0 | 0 | 0900006480f7f1bd | |||
| FDA-2011-N-0003-0043 | FDA | None FDA-2011-N-0003 | Eprinomectin Extended- Release Injectable Parasiticide for Cattle NADA 141-327 - Environmental Impact Assessment | Supporting & Related Material | Environmental Assessment | 2011-12-06T05:00:00Z | 2011 | 12 | 2011-12-06T21:48:41Z | 0 | 0 | 0900006480f7c8c5 | |||
| FDA-2011-N-0003-0042 | FDA | None FDA-2011-N-0003 | Eprinomectin Extended- Release Injectable Parasiticide for Cattle NADA 141-327- Finding of no Significant Impact | Supporting & Related Material | Finding of no Significant Impact | 2011-12-06T05:00:00Z | 2011 | 12 | 2011-12-06T21:39:57Z | 0 | 0 | 0900006480f7c8c4 | |||
| FDA-2011-N-0003-0041 | FDA | None FDA-2011-N-0003 | LONGRANGE (eprinomectin) Extended- Release Injectable Parasiticide NADA 141-327- Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2011-12-05T05:00:00Z | 2011 | 12 | 2011-12-05T16:17:41Z | 0 | 0 | 0900006480f7a085 | |||
| FDA-2011-N-0003-0040 | FDA | None FDA-2011-N-0003 | Ophthalmic and Topical Dosage Form New Animal Drugs; Eprinomectin | Rule | Final Rule | 2011-11-25T05:00:00Z | 2011 | 11 | 2011-11-25T05:00:00Z | 2011-11-25T14:20:46Z | 2011-30328 | 0 | 0 | 0900006480f73670 | |
| FDA-2011-N-0003-0039 | FDA | None FDA-2011-N-0003 | Animal Drugs, Feeds, and Related Products; Eprinomectin; N-Methyl-2-Pyrrolidone | Rule | Final Rule | 2011-11-25T05:00:00Z | 2011 | 11 | 2011-11-25T14:23:01Z | 2011-30329 | 0 | 0 | 0900006480f73650 | ||
| FDA-2011-N-0003-0037 | FDA | None FDA-2011-N-0003 | New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin; Tylosin | Rule | Final Rule | 2011-10-20T04:00:00Z | 2011 | 10 | 2011-10-20T04:00:00Z | 2011-10-20T14:02:09Z | 2011-27139 | 0 | 0 | 0900006480f56b31 | |
| FDA-2011-N-0003-0038 | FDA | None FDA-2011-N-0003 | Heifermax 500 Plus Rumensin and Tylan (melengestrol acetate plus monensin and tylosin phosphate) ANDA 200-375 - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2011-10-20T04:00:00Z | 2011 | 10 | 2011-12-05T17:13:59Z | 0 | 0 | 0900006480f56c9a | |||
| FDA-2011-N-0003-0035 | FDA | None FDA-2011-N-0003 | New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin | Rule | Final Rule | 2011-09-30T04:00:00Z | 2011 | 9 | 2011-09-30T04:00:00Z | 2011-09-30T13:05:07Z | 2011-25220 | 0 | 0 | 0900006480f45b6a | |
| FDA-2011-N-0003-0036 | FDA | None FDA-2011-N-0003 | Freedom of Information Summary ANDA 200-422 Heifermax 500 plus Rumensin | Other | Freedom of Information Summary (No Federal Register Publication) | 2011-09-30T04:00:00Z | 2011 | 9 | 2011-09-30T04:00:00Z | 2011-09-30T13:13:51Z | 0 | 0 | 0900006480f4344f | ||
| FDA-2011-N-0003-0034 | FDA | None FDA-2011-N-0003 | Tylomed-WS (tylosin tartrate soluble powder) ANDA 200-455 - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2011-09-23T04:00:00Z | 2011 | 9 | 2011-12-05T17:16:18Z | 0 | 0 | 0900006480f28610 | |||
| FDA-2011-N-0003-0033 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Tylosin | Rule | Final Rule | 2011-09-23T04:00:00Z | 2011 | 9 | 2011-09-23T04:00:00Z | 2011-09-23T13:49:15Z | 2011-24461 | 0 | 0 | 0900006480f28536 | |
| FDA-2011-N-0003-0031 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Gamithromycin | Rule | Final Rule | 2011-09-19T04:00:00Z | 2011 | 9 | 2011-09-19T04:00:00Z | 2011-09-19T16:38:18Z | 2011-23874 | 0 | 0 | 0900006480f22065 | |
| FDA-2011-N-0003-0030 | FDA | None FDA-2011-N-0003 | Tolerances for Residues of New Animal Drugs in Food: Progesterone | Rule | Final Rule | 2011-09-19T04:00:00Z | 2011 | 9 | 2011-09-19T04:00:00Z | 2011-09-19T16:31:42Z | 2011-23867 | 0 | 0 | 0900006480f220a7 | |
| FDA-2011-N-0003-0032 | FDA | None FDA-2011-N-0003 | Zactran (gamithomycin injectable solution) (NADA 141-328) - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2011-09-19T04:00:00Z | 2011 | 9 | 2011-12-05T17:18:47Z | 0 | 0 | 0900006480f227f4 | |||
| FDA-2011-N-0003-0028 | FDA | None FDA-2011-N-0003 | Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin | Rule | Final Rule | 2011-09-19T04:00:00Z | 2011 | 9 | 2011-09-19T04:00:00Z | 2011-09-19T16:03:53Z | 2011-23865 | 0 | 0 | 0900006480f22114 | |
| FDA-2011-N-0003-0029 | FDA | None FDA-2011-N-0003 | Bimectin Injectable Solution (ivermectin) (ANADA 200-447) - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2011-09-19T04:00:00Z | 2011 | 9 | 2011-12-05T17:20:22Z | 0 | 0 | 0900006480f22608 | |||
| FDA-2011-N-0003-0027 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Ampicillin Trihydrate, Bacitracin Methylene Disalicylate, Flunixin, etc.; Correcting Amendments | Rule | Correction | 2011-08-25T04:00:00Z | 2011 | 8 | 2011-08-25T13:40:34Z | 2011-21721 | 0 | 0 | 0900006480eee4b8 | ||
| FDA-2011-N-0003-0026 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Change of Sponsor; Chlortetracycline; Sulfamethazine | Rule | Final Rule | 2011-08-11T04:00:00Z | 2011 | 8 | 2011-08-11T13:46:29Z | 2011-20404 | 0 | 0 | 0900006480edde3b | ||
| FDA-2011-N-0003-0025 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor; Moxidectin | Rule | Final Rule | 2011-08-09T04:00:00Z | 2011 | 8 | 2011-08-09T04:00:00Z | 2011-08-09T14:46:08Z | 2011-20182 | 0 | 0 | 0900006480edbacf | |
| FDA-2011-N-0003-0023 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Amprolium | Rule | Final Rule | 2011-07-12T04:00:00Z | 2011 | 7 | 2011-07-12T04:00:00Z | 2011-07-12T14:34:01Z | 2011-17465 | 0 | 0 | 0900006480ec062c | |
| FDA-2011-N-0003-0024 | FDA | None FDA-2011-N-0003 | Ampromed P (amprolium) (ANADA 200-488) - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2011-07-12T04:00:00Z | 2011 | 7 | 2011-12-05T17:21:57Z | 0 | 0 | 0900006480ec0a71 | |||
| FDA-2011-N-0003-0022 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor's Name and Address | Rule | Final Rule | 2011-07-11T04:00:00Z | 2011 | 7 | 2011-07-11T04:00:00Z | 2011-07-11T13:50:45Z | 2011-17292 | 0 | 0 | 0900006480ebef6a | |
| FDA-2011-N-0003-0021 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs; Change of Sponsor | Rule | Final Rule | 2011-07-08T04:00:00Z | 2011 | 7 | 2011-07-08T04:00:00Z | 2011-07-08T19:06:59Z | 2011-17151 | 0 | 0 | 0900006480ebcfab | |
| FDA-2011-N-0003-0020 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Change of Sponsor's Address | Rule | Final Rule | 2011-07-06T04:00:00Z | 2011 | 7 | 2011-07-06T04:00:00Z | 2011-07-06T18:50:24Z | 2011-16845 | 0 | 0 | 0900006480eba135 | |
| FDA-2011-N-0003-0019 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Amprolium | Rule | Final Rule | 2011-07-01T04:00:00Z | 2011 | 7 | 2011-07-01T04:00:00Z | 2011-07-01T14:40:14Z | 2011-16501 | 0 | 0 | 0900006480eb82fd | |
| FDA-2011-N-0003-0017 | FDA | None FDA-2011-N-0003 | Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor-Diphtheria Toxoid Conjugate | Rule | NFR-Notice of Final Rule | 2011-05-13T04:00:00Z | 2011 | 5 | 2011-05-13T04:00:00Z | 2011-05-13T12:55:58Z | 2011-11762 | 0 | 0 | 0900006480c79e08 | |
| FDA-2011-N-0003-0018 | FDA | None FDA-2011-N-0003 | Freedom Of Information Summary - [NADA 141-322] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2011-05-13T04:00:00Z | 2011 | 5 | 2011-05-13T13:04:01Z | 0 | 0 | 0900006480c79711 | |||
| FDA-2011-N-0003-0015 | FDA | None FDA-2011-N-0003 | Implantation or Injectable Dosage Form New Animal Drugs: Enrofloxacin | Rule | NFR-Notice of Final Rule | 2011-04-22T04:00:00Z | 2011 | 4 | 2011-04-22T04:00:00Z | 2011-04-22T13:02:12Z | 2011-09765 | 0 | 0 | 0900006480c35d41 | |
| FDA-2011-N-0003-0016 | FDA | None FDA-2011-N-0003 | Freedom Of Information Summary [ NADA 141-068] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2011-04-22T04:00:00Z | 2011 | 4 | 2011-04-22T13:13:04Z | 0 | 0 | 0900006480c35ae1 | |||
| FDA-2011-N-0003-0013 | FDA | None FDA-2011-N-0003 | Attachment - Veterinary insert for Product carton - [Freedom Of Information Summary - NADA 141-320 [ONSIOR Robenacoxib Tablets Cats] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2011-04-20T04:00:00Z | 2011 | 4 | 2011-04-20T17:24:19Z | 0 | 0 | 0900006480c33a6c | |||
| FDA-2011-N-0003-0014 | FDA | None FDA-2011-N-0003 | Attachment - Owner insert for dispensing envelope - [Freedom Of Information Summary - NADA 141-320 [ONSIOR Robenacoxib Tablets Cats] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2011-04-20T04:00:00Z | 2011 | 4 | 2011-04-20T17:28:01Z | 0 | 0 | 0900006480c33a9b | |||
| FDA-2011-N-0003-0012 | FDA | None FDA-2011-N-0003 | Freedom Of Information Summary - NADA 141-320 [ONSIOR Robenacoxib Tablets Cats] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2011-04-05T04:00:00Z | 2011 | 4 | 2011-04-05T14:04:47Z | 0 | 0 | 0900006480c1b79a | |||
| FDA-2011-N-0003-0011 | FDA | None FDA-2011-N-0003 | Oral Dosages Form New Animal Drugs: Robenacoxib | Rule | NFR-Notice of Final Rule | 2011-04-05T04:00:00Z | 2011 | 4 | 2011-04-05T04:00:00Z | 2011-04-05T13:54:22Z | 2011-08053 | 0 | 0 | 0900006480c1bc56 | |
| FDA-2011-N-0003-0009 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Amikacin Sulfate, Ampicillin Trihydrate, Ceftiofur Hydrochloride, Cephapirin Benzathine, etc.; Correcting Amendments | Rule | NCR-Notice of Correction | 2011-03-29T04:00:00Z | 2011 | 3 | 2011-03-29T04:00:00Z | 2011-03-29T13:29:20Z | 2011-07313 | 0 | 0 | 0900006480c1279e | |
| FDA-2011-N-0003-0010 | FDA | None FDA-2011-N-0003 | Freedom Of Information Summary - 200-026 [PENNOX 343] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2011-03-29T04:00:00Z | 2011 | 3 | 2011-03-29T13:44:53Z | 0 | 0 | 0900006480c12b4e | |||
| FDA-2011-N-0003-0007 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Oxytetracycline | Rule | NFR-Notice of Final Rule | 2011-03-28T04:00:00Z | 2011 | 3 | 2011-03-28T04:00:00Z | 2011-03-28T14:44:26Z | 2011-07216 | 0 | 0 | 0900006480c11e79 | |
| FDA-2011-N-0003-0008 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Arsanilate Sodium; Sulfaethoxypyridazine | Rule | NFR-Notice of Final Rule | 2011-03-28T04:00:00Z | 2011 | 3 | 2011-03-28T04:00:00Z | 2011-03-28T14:56:22Z | 2011-07214 | 0 | 0 | 0900006480c11e7a | |
| FDA-2011-N-0003-0006 | FDA | None FDA-2011-N-0003 | Tolerances for Residues of New Animal Drugs in Food: 2-Acetylamino-5-Nitrothiazole; Buquinolate; Chlorobutanol; Estradiol and Related Esters, etc.; Correcting Amendments | Rule | NFR-Notice of Final Rule | 2011-03-25T04:00:00Z | 2011 | 3 | 2011-03-25T04:00:00Z | 2011-03-25T15:07:49Z | 2011-06796 | 0 | 0 | 0900006480c10d09 | |
| FDA-2011-N-0003-0004 | FDA | None FDA-2011-N-0003 | Oral Dosage Form New Animal Drugs: Spinosad and Milbemycin Oxime | Rule | NFR-Notice of Final Rule | 2011-03-08T05:00:00Z | 2011 | 3 | 2011-03-08T05:00:00Z | 2011-03-08T16:02:16Z | 2011-05144 | 0 | 0 | 0900006480c0323d | |
| FDA-2011-N-0003-0005 | FDA | None FDA-2011-N-0003 | Freedom Of Information Summary- 141-321 [TRIFEXIS Spinosad and Milbemycin oxime Chewable Tablets Dogs] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2011-03-08T05:00:00Z | 2011 | 3 | 2011-03-08T16:19:23Z | 0 | 0 | 0900006480c02cd8 | |||
| FDA-2011-N-0003-0003 | FDA | None FDA-2011-N-0003 | Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications: Phenylbutazone; Pyrantel; Tylosin | Notice | NFR-Notice of Final Rule | 2011-03-02T05:00:00Z | 2011 | 3 | 2011-03-02T17:54:11Z | 2011-04546 | 0 | 0 | 0900006480bfcca3 | ||
| FDA-2011-N-0003-0001 | FDA | None FDA-2011-N-0003 | New Animal Drugs: Masitinib | Rule | NFR-Notice of Final Rule | 2011-02-04T05:00:00Z | 2011 | 2 | 2011-02-04T05:00:00Z | 2011-02-04T15:32:40Z | 2011-2519 | 0 | 0 | 0900006480bdbad8 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;